Financials

News Ideas Discussions Technicals Forecast Seasonals

RX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of BIOSYENT INC

Total assets of RX for Q2 24 is 41.48 M CAD, 3.71% more than the previous Q1 24. And total liabilities increased by 11.31% in Q2 24 to 6.06 M CAD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: CAD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—